National recommendations document on the follow-up of patients with renal cell carcinoma.

Autor: Juárez Á; Unidad de Gestión Clínica de Urología, Hospital de Jerez de la Frontera, Cádiz, España., Álvarez-Ossorio JL; Unidad de Gestión Clínica de Urología, Hospital Universitario Puerta del Mar, Cádiz, España., Carballido J; Servicio de Urología, Hospital Puerta de Hierro, Madrid, España., Llarena R; Servicio de Urología, Hospital Universitario Cruces, Baracaldo, Vizcaya, España., Medina R; Unidad Clínica Urología-Nefrología, Hospital Universitario Virgen del Rocío, Sevilla, España., Moreno J; Unidad de Gestión Clínica de Urología, Complejo Hospitalario de Jaén, Jaén, España., Sánchez E; Unidad de Gestión Clínica de Urología, Hospital Regional Virgen Macarena, Sevilla, España., Vázquez F; Unidad de Gestión Clínica de Urología, Hospital Universitario Virgen de las Nieves, Granada, España., Cózar JM; Unidad de Gestión Clínica de Urología, Hospital Universitario Virgen de las Nieves, Granada, España. Electronic address: cozarjm@yahoo.es.
Jazyk: English; Spanish; Castilian
Zdroj: Actas urologicas espanolas [Actas Urol Esp (Engl Ed)] 2018 Jul-Aug; Vol. 42 (6), pp. 381-388. Date of Electronic Publication: 2018 Feb 02.
DOI: 10.1016/j.acuro.2017.11.004
Abstrakt: Objectives: This document was developed to establish directives for the follow-up of patients with renal cell carcinoma (RCC) based on the best available scientific evidence and on expert opinions, which can help urologists in the decision-making process and standardise the criteria at the national level.
Material and Methods: The methodology is based on the RAND/UCLA method. A panel of 9 experts on RCC participated in designing a thematic index, identifying and reading the available evidence, formulating recommendations and drafting the content. A validating group of 25 experts, who did not participate in the previous phases, assessed the recommendations through anonymous voting in a face-to-face consensus meeting. The recommendations that were agreed upon by 75% or more of the participants in this vote were accepted as consensus. The recommendations that did not achieve this consensus were rejected.
Results: A total of 25 recommendations were accepted as consensus. These recommendations cover the laboratory tests, clinical assessment tests and imaging tests that should be performed for patients with RCC. The presented recommendations have been adapted according to relapse risk. The current document also outlines the frequency and duration of follow-up for each patient profile.
Conclusions: The current document enables standardisation of the follow-up criteria for patients with RCC treated in the Spanish healthcare setting, according to the patients' relapse risk.
(Copyright © 2017 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: